trial
as of 2026-07-01Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
NCTId NCT03067311
at a glance
— · Completed
Enrollment 38 (actual)
Sponsored by University of North Carolina, Chapel Hill
Primary completion 2020-03-30
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
38 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2016-10-03
Primary completion
2020-03-30
Eligibility
ALL · 15 Years · 35 Years
Interventions & indications
Drugs
Sponsors
University of North Carolina, Chapel HillLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Investigators
3
David L. Penn, PhDPrincipal Investigator
Diana O. Perkins, MD, MPHPrincipal Investigator
Piper S Meyer-Kalos, PhDPrincipal Investigator
Sites
4 total
Carrboro, United StatesCarrboro, United StatesRaleigh, United StatesRaleigh, United States
Facts & assertions
4 sourced
Enrollment
38
Phase
NA
Primary Completion Date
2020-03-30
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
investigator